These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 3077625)

  • 1. Properties of target molecule of murine lymphokine-activated killer (LAK) cells and the clones.
    Hashimoto Y; Kato K; Sato N; Yagi H; Yagita H; Nishimura T
    Princess Takamatsu Symp; 1988; 19():315-22. PubMed ID: 3077625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Establishment of mouse lymphokine-activated killer cell clones and their properties.
    Kato K; Sato N; Tanabe T; Yagita H; Agatsuma T; Hashimoto Y
    Jpn J Cancer Res; 1991 Apr; 82(4):456-63. PubMed ID: 1904425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increase in tumor necrosis factor-alpha mRNA but not perforin mRNA expression in response to two newly characterized anti-LFA-1 monoclonal antibodies.
    Hommel-Berrey G; Bochan M; Brahmi Z
    Nat Immun; 1994; 13(6):301-14. PubMed ID: 7894201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dimethyl 2,2-dichlorovinyl phosphate (DDVP) markedly inhibits activities of natural killer cells, cytotoxic T lymphocytes and lymphokine-activated killer cells via the Fas-ligand/Fas pathway in perforin-knockout (PKO) mice.
    Li Q; Nakadai A; Takeda K; Kawada T
    Toxicology; 2004 Nov; 204(1):41-50. PubMed ID: 15369847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A murine very late activation antigen-like extracellular matrix receptor involved in CD2- and lymphocyte function-associated antigen-1-independent killer-target cell interaction.
    Takahashi K; Nakamura T; Koyanagi M; Kato K; Hashimoto Y; Yagita H; Okumura K
    J Immunol; 1990 Dec; 145(12):4371-9. PubMed ID: 1979586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression and function of LFA-1 on A-NK and T-LAK cells: role in tumor target killing and migration into tumor tissue.
    Donskov F; Basse PH; Hokland M
    Nat Immun; 1996-1997; 15(2-3):134-46. PubMed ID: 9162263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymphokine-activated killer cells. VII. IL-4 induces an NK1.1+CD8 alpha+beta- TCR-alpha beta B220+ lymphokine-activated killer subset.
    Ballas ZK; Rasmussen W
    J Immunol; 1993 Jan; 150(1):17-30. PubMed ID: 7678028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of the murine lymphokine-activated killer (LAK) cell phenomenon: dissection of effectors and progenitors into NK- and T-like cells.
    Kalland T; Belfrage H; Bhiladvala P; Hedlund G
    J Immunol; 1987 Jun; 138(11):3640-5. PubMed ID: 3495566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Augmentation by anti-T3 antibody of the lymphokine-activated killer cell-mediated cytotoxicity.
    Ting CC; Hargrove ME; Yun YS
    J Immunol; 1988 Aug; 141(3):741-8. PubMed ID: 3260909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential lysis of tumor target cells displayed by lymphokine activated killer (LAK) cell clones.
    Bean P; Agah R; Mazumder A
    Int J Cell Cloning; 1992 May; 10(3):190-5. PubMed ID: 1613270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two types of anti-TL (thymus leukemia) CTL clones with distinct target specificities: differences in cytotoxic mechanisms and accessory molecule requirements.
    Tsujimura K; Takahashi T; Iwase S; Matsudaira Y; Kaneko Y; Yagita H; Obata Y
    J Immunol; 1998 Jun; 160(11):5253-61. PubMed ID: 9605121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in homing receptor expression on murine lymphokine-activated killer cells during IL-2 exposure.
    Steen PD; McGregor JR; Lehman CM; Samlowski WE
    J Immunol; 1989 Dec; 143(12):4324-30. PubMed ID: 2687380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cooperation between CD44 and LFA-1/CD11a adhesion receptors in lymphokine-activated killer cell cytotoxicity.
    Matsumoto G; Nghiem MP; Nozaki N; Schmits R; Penninger JM
    J Immunol; 1998 Jun; 160(12):5781-9. PubMed ID: 9637488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perforin, Fas ligand, and tumor necrosis factor are the major cytotoxic molecules used by lymphokine-activated killer cells.
    Lee RK; Spielman J; Zhao DY; Olsen KJ; Podack ER
    J Immunol; 1996 Sep; 157(5):1919-25. PubMed ID: 8757310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolation and characterization of cytotoxic granules from human lymphokine (interleukin 2) activated killer cells.
    Lowrey DM; Hameed A; Lichtenheld M; Podack ER
    Cancer Res; 1988 Aug; 48(16):4681-8. PubMed ID: 3260817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular studies on LAK cells.
    Fagioli M; Carè A; Ciccone E; Moretta L; Moretta A; Testa U; Falini B; Grignani F; Peschle C; Pelicci PG
    Ann Ist Super Sanita; 1990; 26(3-4):357-68. PubMed ID: 1982603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenotypic and functional characterization of recombinant interleukin 2 (rIL 2)-induced activated killer cells: analysis at the population and clonal levels.
    Ferrini S; Miescher S; Zocchi MR; von Fliedner V; Moretta A
    J Immunol; 1987 Feb; 138(4):1297-302. PubMed ID: 3100633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heterogeneity of long-term cultured activated killer cells induced by anti-T3 antibody.
    Yun YS; Hargrove ME; Ting CC
    J Immunol; 1988 Aug; 141(4):1390-7. PubMed ID: 3260924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of electric foot shock and psychological stress on activities of murine splenic natural killer and lymphokine-activated killer cells, cytotoxic T lymphocytes, natural killer receptors and mRNA transcripts for granzymes and perforin.
    Li Q; Liang Z; Nakadai A; Kawada T
    Stress; 2005 Jun; 8(2):107-16. PubMed ID: 16019602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined therapy of mice bearing a lymphokine-activated killer-resistant tumor with recombinant interleukin 2 and an antitumor monoclonal antibody capable of inducing antibody-dependent cellular cytotoxicity.
    Kawase I; Komuta K; Hara H; Inoue T; Hosoe S; Ikeda T; Shirasaka T; Yokota S; Tanio Y; Masuno T
    Cancer Res; 1988 Mar; 48(5):1173-9. PubMed ID: 3257715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.